Velocity.Partners

We are very proud to see one of our first investments announcing an exciting exit!

Costas Alexoglou, Konstantinos Xanthopoulos, Jim Raptis, Nikolaos Paschos and the rest of the Loceye team have been working tirelessly the past 5 years on delivering a state-of-the-art platform focusing on web-based predictive analytics (along with its AI design assistant VisualEyes) that has been trusted by thousands of designers and enthusiasts worldwide, and are now setting another great milestone for the Greek startup ecosystem.

We are happy that the company is now passing on to the experienced hands of Mike Storm, Thomas Zoëga Ramsøy, Dennis Green-Lieber from Neurons, who will be continuing the quest to provide predictive analytics and work towards taking the product to greater heights.

Neurons acquires Greek platforms to take customer prediction to the next level The acquisition by the Danish company is expected to revolutionise the way brands understand and predict customer behaviour.

We are very happy to see our portfolio company intelligencia.ai successfully raising its Series A round, led by its amazing founders Dimitrios Skaltsas and Vangelis Vergetis!

Based in New York City and Athens, Intelligencia applies predictive analytics to estimate the probability of success for clinical trials and optimize their design, enabling pharmaceutical and biotechnology companies to revolutionize the drug development process and reduce associated risks.

https://www.businesswire.com/news/home/20210810005501/en/Intelligencia-Raises-12M-to-Reduce-the-Risk-of-Clinical-Research-Improve-RD-Productivity-and-Accelerate-Scientific-Breakthroughs

Intelligencia Raises $12M to Reduce the Risk of Clinical Research, Improve R&D Productivity, and Accelerate Scientific Breakthroughs Intelligencia, whose AI-driven software platform enables pharmaceutical and biotechnology companies to revolutionize the drug development process and

SERG Technologies (https://sergtechnologies.com/) has embarked on a journey to help improve the lives of millions of patients worldwide suffering from Parkinson's Disease. By combining machine learning with wearable sensors, SERG is able to keep track of the patient's progress in a completely remote manner, meaning that treatment & diagnosis becomes accessible to more people than ever before.

https://www.bbc.com/news/technology-57342760

Parkinson's, AI and me The BBC's tech correspondent looks at how AI could change the treatment of Parkinson's disease.